2015 annual financial data
Nektar Therapeutics 2015 Operating margin
Nektar Therapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was -12.73%.
Operating income was -29,371,000 USD and net income was -81,177,000 USD.
Operating cash flow was -73,083,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 230,784,000 USD
- Operating income
- -29,371,000 USD
- Net income
- -81,177,000 USD
- Operating cash flow
- -73,083,000 USD